Today
Executive Summary
Sponge is now "leading brand in the vaginal contraceptive category in both dollars and units sold to drugstores," VLI said in May 11 first quarter report to shareholders. Nearly 13 mil. sponges have been sold to about 500,000 users. For quarter ended March 31 VLI volume increased about 45% to $3.4 mil.; the firm showed net earnings of $305,027 v. a $32,817 loss in same quarter last year.